A Multicenter phase II study of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanved non-squamous non-small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Bevacizumab (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 02 Jun 2015 Primary endpoint (Progression-free survival duration) has not been met, according to results reported in ASCO 2015 abstract.
- 02 Jun 2015 Status changed from recruiting to completed. according to results reported in ASCO 2015 abstract.